A Study of CDX-622 in Participants With Mild to Moderate Asthma

Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma

NCT04946318 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Immunogenicity of APG777 in Adults With Asthma

NCT06920901 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability and Plasma Concentration Profiles of MK0633 in Asthmatic Children Aged 12 to Less Than 16 Years (0633-019)

NCT00646789 ·Status: COMPLETED ·Phase: PHASE1

Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma

NCT04410523 ·Status: TERMINATED ·Phase: PHASE2

Plasma Levels of MK0633 in Children Ages 6-12 (0633-023)

NCT00751413 ·Status: COMPLETED ·Phase: PHASE1

Study to Assess the Safety and Efficacy of SelK2 on Airway Responses Following Allergen Challenge in Subjects With Asthma (Part 1) and in Subjects With Chronic Obstructive Pulmonary Disease (Part 2)

NCT04540042 ·Status: COMPLETED ·Phase: PHASE2

Airway Immune Response to Allergens (Use Lay Language Here)

NCT04619017 ·Status: UNKNOWN ·Phase: PHASE1

The Effect of MK0633 in Patients With Chronic Asthma (0633-007)

NCT00404313 ·Status: TERMINATED ·Phase: PHASE2

A Study of MK0359 in Patients With Chronic Asthma (0359-013)

NCT00482898 ·Status: COMPLETED ·Phase: PHASE2

A Study to Investigate the Efficacy, Safety, and Tolerability of Repeat Doses of Inhaled GSK2269557 in Adults With Persistent, Uncontrolled Asthma

NCT02567708 ·Status: COMPLETED ·Phase: PHASE2

A Safety Study Evaluating N6022 in Multiple-Ascending Doses in Healthy Subjects

NCT01339897 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of CRD007 in Adult Asthma Subjects

NCT02615080 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Inhaled Montelukast (MK-0476) in Participants With Mild or Moderate Asthma (MK-0476-380 AM3)(COMPLETED)

NCT00636207 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Efficacy After Allergen Challenge, Safety and Tolerability of Inhaled CHF6001 DPI in Asthmatics

NCT01689571 ·Status: COMPLETED ·Phase: PHASE2

Intravenous Microdose Pharmacokinetic (PK) Study With [14C]-GSK2239633

NCT01086462 ·Status: COMPLETED ·Phase: PHASE1

A Single Ascending Dose Study in Healthy Participants and Multiple Ascending Dose Study of CNTO 7160 in Participants With Asthma and Participants With Atopic Dermatitis

NCT02345928 ·Status: COMPLETED ·Phase: PHASE1

Study to Examine the Cytokine Levels, Gene Expression and Safety of a Single Nasal Dose of JNJ-43260295, in Healthy Participants, and Atopic Participants With Mild to Mild-Persistent Asthma

NCT02243189 ·Status: TERMINATED ·Phase: PHASE1

A Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD7594 Administered Once Daily by Inhalation in Asthmatic Subjects

NCT03622112 ·Status: COMPLETED ·Phase: PHASE2

A Phase 1 Study of CNTO 3157 in Healthy Volunteers and Patients With Asthma

NCT01195207 ·Status: COMPLETED ·Phase: PHASE1

Multiple Rising Oral Doses of BI 1060469 in Healthy Subjects and Mild Asthma Patients

NCT02126865 ·Status: COMPLETED ·Phase: PHASE1

A Single-Arm Phase Ic Clinical Study of XKH001 Injection in Patients With Allergic Asthma After Multiple Doses

NCT07070297 ·Status: COMPLETED ·Phase: PHASE1

A Study Of GSK679586A When Infused Into Healthy And Mild Asthmatic Volunteers

NCT00411814 ·Status: COMPLETED ·Phase: PHASE1

Single and Multiple Ascending Dose Study of TD-8236 by Inhalation

NCT03652038 ·Status: COMPLETED ·Phase: PHASE1

Therapeutic Relevance of Abnormal Airway Morphology in Asthma

NCT06970080 ·Status: RECRUITING ·Phase: PHASE4

Clinical Study on the Efficacy and Safety of SHR-4597 Inhalant in Adult Patients With Asthma

NCT06940700 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2